Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirus

Human antibody technology and the development of antibodies against cytomegalovirus

(2015) Mats Ohlin et al.   MOLECULAR IMMUNOLOGY

Crystal Structure of the Human Cytomegalovirus Glycoprotein B

(2015) Heidi G. Burke et al.   PLoS Pathogens

A High-Affinity Native Human Antibody Neutralizes Human Cytomegalovirus Infection of Diverse Cell Types

(2014) Lawrence M. Kauvar et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A new look at a poorly immunogenic neutralization epitope on cytomegalovirus glycoprotein B. Is there cause for antigen redesign?

(2014) Mats Ohlin   MOLECULAR IMMUNOLOGY

Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine

(2013) D. C. Freed et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Immunogenicity in mice and non-human primates of the Group A Streptococcal J8 peptide vaccine candidate conjugated to CRM197

(2013) Ivette Caro-Aguilar et al.   Human Vaccines & Immunotherapeutics

Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation

(2012) Paul D Griffiths   LANCET INFECTIOUS DISEASES

Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus

(2012) Tong-Ming Fu et al.   VACCINE

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

(2011) Paul D Griffiths et al.   LANCET

Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells

(2011) M. B. Reeves et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines

(2011) Aimin Tang et al.   VACCINE

Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection

(2011) Dai Wang et al.   VACCINE

Structural Basis of Local, pH-Dependent Conformational Changes in Glycoprotein B from Herpes Simplex Virus Type 1

(2010) S. D. Stampfer et al.   JOURNAL OF VIROLOGY

Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates

(2010) E. Bianchi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Overview of the development and current use of CRM197 conjugate vaccines for pediatric use

(2010) Henry R. Shinefield   VACCINE

Isolation of Human Monoclonal Antibodies That Potently Neutralize Human Cytomegalovirus Infection by Targeting Different Epitopes on the gH/gL/UL128-131A Complex

(2009) A. Macagno et al.   JOURNAL OF VIROLOGY

Human Cytomegalovirus Glycoprotein B Is Required for Virus Entry and Cell-to-Cell Spread but Not for Virion Attachment, Assembly, or Egress

(2009) M. K. Isaacson et al.   JOURNAL OF VIROLOGY

Vaccine Prevention of Maternal Cytomegalovirus Infection

(2009) Robert F. Pass et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys

(2009) Tong-Ming Fu et al.   VACCINE

Entry of herpesviruses into mammalian cells

(2008) E. E. Heldwein et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Amino Acid Analysis of Peptide Loading Ratios in Conjugate Vaccines: A Comparison of Direct Electrochemical Detection and 6-Aminoquinolyl-N-Hydroxysuccinimidyl Carbamate Pre-Column Derivatization Methods

(2007) Deborah D. Nahas et al.   BIOCONJUGATE CHEMISTRY